Pages that link to "Q34350247"
Jump to navigation
Jump to search
The following pages link to Clinical relevance of positive voltage-gated potassium channel (VGKC)-complex antibodies: experience from a tertiary referral centre (Q34350247):
Displaying 50 items.
- From VGKC to LGI1 and Caspr2 encephalitis: The evolution of a disease entity over time (Q26739918) (← links)
- Antibody-associated epilepsies: Clinical features, evidence for immunotherapies and future research questions (Q26741919) (← links)
- The Diagnosis and Treatment of Autoimmune Encephalitis (Q26769676) (← links)
- Autoantibodies to central nervous system neuronal surface antigens: psychiatric symptoms and psychopharmacological implications (Q26775915) (← links)
- Clinical and experimental studies of potentially pathogenic brain-directed autoantibodies: current knowledge and future directions (Q26824216) (← links)
- Cell-surface central nervous system autoantibodies: clinical relevance and emerging paradigms (Q27006941) (← links)
- Antibody-Mediated Autoimmune Encephalopathies and Immunotherapies (Q28084055) (← links)
- Recognizing Autoimmune-Mediated Encephalitis in the Differential Diagnosis of Limbic Disorders (Q28087810) (← links)
- Autoimmune encephalopathies (Q30389491) (← links)
- Complement-associated neuronal loss in a patient with CASPR2 antibody-associated encephalitis (Q30417469) (← links)
- Emergence of new-onset psychotic disorder following recovery from LGI1 antibody-associated limbic encephalitis (Q33552867) (← links)
- Advances in Autoimmune Epilepsy Associated with Antibodies, Their Potential Pathogenic Molecular Mechanisms, and Current Recommended Immunotherapies (Q33600142) (← links)
- Presence of voltage-gated potassium channel complex antibody in a case of genetic prion disease (Q33743698) (← links)
- Gerstmann-Straüssler-Scheinker disease: novel PRNP mutation and VGKC-complex antibodies (Q33987193) (← links)
- An 11-year retrospective experience of antibodies against the voltage-gated potassium channel (VGKC) complex from a tertiary neurological centre (Q34449781) (← links)
- Neuronal surface antibody-mediated autoimmune encephalitis. (Q35392781) (← links)
- Encephalitis due to antibodies to voltage gated potassium channel (VGKC) with cerebellar involvement in a teenager (Q35651879) (← links)
- Neuronal antibodies in patients with suspected or confirmed sporadic Creutzfeldt-Jakob disease (Q35677785) (← links)
- Posterior cortical and white matter changes on MRI in anti-AMPA receptor antibody encephalitis (Q35693056) (← links)
- Clinical relevance of voltage-gated potassium channel–complex antibodies in children (Q36052949) (← links)
- Clinical spectrum and diagnostic value of antibodies against the potassium channel related protein complex (Q36760291) (← links)
- Determination of neuronal antibodies in suspected and definite Creutzfeldt-Jakob disease (Q36813368) (← links)
- A clinical approach to diagnosis of autoimmune encephalitis. (Q37343730) (← links)
- Isaacs syndrome: A review (Q38367371) (← links)
- Autoimmune encephalitis (Q38743365) (← links)
- Emerging psychiatric syndromes associated with antivoltage-gated potassium channel complex antibodies (Q38902329) (← links)
- Clinical utility of seropositive voltage-gated potassium channel-complex antibody (Q39009676) (← links)
- The value of LGI1, Caspr2 and voltage-gated potassium channel antibodies in encephalitis (Q39247906) (← links)
- Autoantibodies against voltage-gated potassium channel and glutamic acid decarboxylase in psychosis: A systematic review, meta-analysis, and case series (Q39345643) (← links)
- Neuronal antibodies in pediatric epilepsy: Clinical features and long-term outcomes of a historical cohort not treated with immunotherapy. (Q39903518) (← links)
- Expanded phenotypes and outcomes among 256 LGI1/CASPR2-IgG-positive patients. (Q40154528) (← links)
- Mediastinal mass: to resect or not to resect? (Q40306540) (← links)
- Wait and see: a 5 year history of 'recurrent dementia'. (Q42125714) (← links)
- Intracellular and non-neuronal targets of voltage-gated potassium channel complex antibodies (Q42687320) (← links)
- Clinical relevance of serum antibodies to extracellular N-methyl-D-aspartate receptor epitopes (Q43511105) (← links)
- Autoantibody biomarkers in childhood-acquired demyelinating syndromes: results from a national surveillance cohort. (Q44207147) (← links)
- Neuronal autoantibodies: differentiating clinically relevant and clinically irrelevant results (Q46640936) (← links)
- Diagnostics of autoimmune encephalitis associated with antibodies against neuronal surface antigens (Q47654624) (← links)
- Brain-relevant antibodies in first-episode psychosis: a matched case-control study (Q47787761) (← links)
- Prevalence and clinical characteristics of serum neuronal cell surface antibodies in first-episode psychosis: a case-control study (Q47853545) (← links)
- Prevalence of serum anti-neuronal autoantibodies in patients admitted to acute psychiatric care. (Q47942669) (← links)
- Infliximab-associated autoimmune limbic encephalitis: a case report (Q48700956) (← links)
- Anti-collapsin response mediator protein 5 encephalitis masquerading as a low-grade brain tumour (Q48703564) (← links)
- Outcome of limbic encephalitis with VGKC-complex antibodies: relation to antigenic specificity (Q48712459) (← links)
- Neuronal autoantibodies in mesial temporal lobe epilepsy with hippocampal sclerosis. (Q48763396) (← links)
- Possible anti-VGKC autoimmune limbic encephalitis associated with SIADH. (Q50532067) (← links)
- Relevance of Surface Neuronal Protein Autoantibodies as Biomarkers in Seizure-Associated Disorders (Q90193710) (← links)
- Autoimmune Channelopathies at Neuromuscular Junction (Q92478822) (← links)
- Intravenous immunoglobulin and rituximab versus placebo treatment of antibody-associated psychosis: study protocol of a randomised phase IIa double-blinded placebo-controlled trial (SINAPPS2) (Q92591239) (← links)
- Autoimmune Encephalitis (Q92897621) (← links)